(Clin Ter[TA])
8,467 results
  • From Dysbiosis to Malignancy: The Female Genital Tract Microbiome in Endometrial Cancer; Insights from a Systematic Review and Meta-Analysis. [Systematic Review]
    Clin Ter. 2026 Nov-Dec; 177(6):1698-1713.Selim AMF, Ibrahim MMLG, … Elshahat EFCT
  • CONCLUSIONS: Female genital tract microbial dysbiosis is associated with EC, characterized particularly by depletion of potentially protective microorganisms and enrichment of potentially pathogenic or infection-associated taxa. These microbial alterations may have potential as adjunctive biomarkers for EC risk stratification and early detection. However, the available observational evidence does not establish a causal role of microbial dysbiosis or infection in endometrial carcinogenesis. Large prospective studies using standardized sampling, sequencing, and analytical methods are required to clarify causality and determine the clinical utility of microbiome-based diagnostic and therapeutic approaches.
  • Medicinal plants vs metronidazole in bacterial vaginosis: a narrative review of evidence from randomized clinical trials. [Review]
    Clin Ter. 2026 Nov-Dec; 177(6):1643-1655.Bhat S, Kiran A, Narasimhaswamy NCT
  • CONCLUSIONS: Medicinal plants appear to be safe and effective alternatives or adjuncts for bacterial vaginosis; however, the heterogeneity in study designs and short follow-up periods limits definitive conclusions. Further well-designed, multicenter randomized trials with standardized protocols and long-term follow-up, along with studies exploring individual plants and their mechanisms of action, are needed to confirm efficacy, safety, and reproducibility and to support evidence-based use.